115 related articles for article (PubMed ID: 38520660)
1. Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing KIAA1522.
Guo Y; Tian S; Li H; Zuo S; Yu C; Sun C
Asia Pac J Clin Oncol; 2024 Mar; ():. PubMed ID: 38520660
[TBL] [Abstract][Full Text] [Related]
2. KLF9 inhibits the proliferation, invasion, and migration of renal cell carcinoma through the SDF-1/CXCR4 axis.
Yu P; Cheng L; Xia WM; Liu DY; Yu JS; Zhou YF; Zheng YJ
Kaohsiung J Med Sci; 2023 Jun; 39(6):587-595. PubMed ID: 37010151
[TBL] [Abstract][Full Text] [Related]
3. PAFAH1B3 is a KLF9 target gene that promotes proliferation and metastasis in pancreatic cancer.
Dong C; Yao J; Wu Z; Hu J; Sun L; Wu Z; Yan J; Yin X
Sci Rep; 2024 Apr; 14(1):9196. PubMed ID: 38649699
[TBL] [Abstract][Full Text] [Related]
4. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.
Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X
Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730
[TBL] [Abstract][Full Text] [Related]
5. KLF9 positively regulates TRIM33 to inhibit abnormal synovial fibroblast proliferation, migration as well as inflammation in rheumatoid arthritis.
Huang D; Tao L; Du X
Immun Inflamm Dis; 2022 Nov; 10(11):e696. PubMed ID: 36301038
[TBL] [Abstract][Full Text] [Related]
6. Partner of NOB1 homolog transcriptionally activated by E2F transcription factor 1 promotes the malignant progression and inhibits ferroptosis of pancreatic cancer.
Yang Q; Yang B; Chen M
Chin J Physiol; 2023; 66(5):388-399. PubMed ID: 37929351
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circ_0130438 suppresses TNF-α-induced proliferation, migration, invasion and inflammation in human fibroblast-like MH7A synoviocytes by regulating miR-130a-3p/KLF9 axis.
Li L; Zhan M; Li M
Transpl Immunol; 2022 Jun; 72():101588. PubMed ID: 35358709
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis.
Lin J; Liao S; Liu Z; Li E; Wu X; Zeng W
Cancer Biol Ther; 2021 Mar; 22(3):257-266. PubMed ID: 33794727
[TBL] [Abstract][Full Text] [Related]
9. KIAA1522 Promotes the Progression of Hepatocellular Carcinoma via the Activation of the Wnt/β-Catenin Signaling Pathway.
Jiang S; Zhang Y; Li Q; Qiu L; Bian B
Onco Targets Ther; 2020; 13():5657-5668. PubMed ID: 32606779
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of KLF9 in airway inflammation in chronic obstructive pulmonary.
Gu P; Wang Z; Yu X; Wu N; Wu L; Li Y; Hu X
Immun Inflamm Dis; 2023 Oct; 11(10):e1043. PubMed ID: 37904708
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-494-3p facilitates the progression of bladder cancer by mediating the KLF9/RGS2 axis.
Xu XH; Sun JM; Chen XF; Zeng XY; Zhou HZ
Kaohsiung J Med Sci; 2022 Nov; 38(11):1070-1079. PubMed ID: 36098468
[TBL] [Abstract][Full Text] [Related]
12. Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells.
Jin Y; Xu L; Zhao B; Bao W; Ye Y; Tong Y; Sun Q; Liu J
Cell Cycle; 2022 May; 21(9):908-920. PubMed ID: 35112997
[TBL] [Abstract][Full Text] [Related]
13. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.
Xing J; Jia Z; Xu Y; Chen M; Yang Z; Chen Y; Han Y
Bioengineered; 2021 Dec; 12(1):7563-7576. PubMed ID: 34612136
[TBL] [Abstract][Full Text] [Related]
14. KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28.
Li Y; Sun Q; Jiang M; Li S; Zhang J; Xu Z; Guo D; Gu T; Wang B; Xiao L; Zhou T; Zhuo W
FASEB J; 2019 Jul; 33(7):7915-7928. PubMed ID: 30913394
[TBL] [Abstract][Full Text] [Related]
15. KIAA1522 is a new biomarker of promoting the tumorigenesis and distant metastasis of colorectal carcinoma.
Yi X; Hu C; Zhang C; Shao K; Sun H; Jiang Y; Sun N; Zhi X
Cell Signal; 2022 Feb; 90():110202. PubMed ID: 34826587
[TBL] [Abstract][Full Text] [Related]
16. LINC00664/miR-411-5p/KLF9 feedback loop contributes to the human oral squamous cell carcinoma progression.
Wang C; Wang Q; Weng Z
Oral Dis; 2023 Mar; 29(2):672-685. PubMed ID: 34582069
[TBL] [Abstract][Full Text] [Related]
17. miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522.
Li Y; Wang Y; Fan H; Zhang Z; Li N
Biochem Biophys Res Commun; 2018 Sep; 504(1):277-282. PubMed ID: 30177391
[TBL] [Abstract][Full Text] [Related]
18. MiR-141 promotes cell proliferation and invasion in non-small cell lung cancer by targeting KLF9.
Kong YJ; Tan XX; Zhang Y; He QJ; Zhao L; Meng Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10370-10378. PubMed ID: 31841191
[TBL] [Abstract][Full Text] [Related]
19. CircNOL10 Acts as a Sponge of miR-135a/b-5p in Suppressing Colorectal Cancer Progression via Regulating KLF9.
Zhang Y; Zhang Z; Yi Y; Wang Y; Fu J
Onco Targets Ther; 2020; 13():5165-5176. PubMed ID: 32606737
[TBL] [Abstract][Full Text] [Related]
20. Novel Biomarker
Yang T; Si Q; Liu M; DU R; Ji L; Zhang X; Su J; Sun H; Wang L; Zhao C; Liu J; Ouyang S; Dai L
Anticancer Res; 2023 Nov; 43(11):4923-4935. PubMed ID: 37909971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
